Showing results (471-480 of 1,598) with videos related to
Sort By:
Pageof 160
Cancer Journal (Sudbury, Mass.)|March 22, 2021
Chimeric Antigen Receptor T Cells for Multiple Myeloma: The Journey So Far-And the Road AheadAndrew J Cowan, Sherilyn A Tuazon, Andrew J Portuguese, et al.Cancer Journal (Sudbury, Mass.)|March 22, 2021
Neurotoxicity Biology and ManagementHusain Danish, Bianca D SantomassoCancer Journal (Sudbury, Mass.)|March 22, 2021
Improving and Maintaining Responses in Pediatric B-Cell Acute Lymphoblastic Leukemia Chimeric Antigen Receptor-T Cell TherapyRahul Arya, David M Barrett, Stephan A Grupp, et al.Cancer Journal (Sudbury, Mass.)|March 22, 2021
Is Adoptive Cellular Therapy With Non-T-Cell Immune Effectors the Future?Alaa Kassim Ali, Mubin Tarannum, Rizwan RomeeCancer Journal (Sudbury, Mass.)|March 22, 2021
Off-the-Shelf Chimeric Antigen Receptor T Cells: How Do We Get There?Norihiro Watanabe, Maksim MamonkinCancer Journal (Sudbury, Mass.)|December 14, 2021
Stereotactic Body Radiotherapy in Oligomestatic/Oligoprogressive Sarcoma: Safety and Effectiveness Beyond Intrinsic RadiosensitivityDaniela Greto, Mauro Loi, Giulia Stocchi, et al.Cancer Journal (Sudbury, Mass.)|December 14, 2021
New Roles of Poly(ADP-Ribose) Polymerase Inhibitors in the Treatment of Breast CancerElizabeth Harvey-Jones, Gemma Vinas Villaro, Andrew TuttCancer Journal (Sudbury, Mass.)|December 14, 2021
PARP Inhibitors in Pancreatic CancerTimothy J Brown, Kim A ReissCancer Journal (Sudbury, Mass.)|December 14, 2021
The Clinical Challenges, Trials, and Errors of Combatting Poly(ADP-Ribose) Polymerase Inhibitors ResistanceMelissa M Pham, Emily Hinchcliff, Monica Avila, et al.Cancer Journal (Sudbury, Mass.)|September 27, 2022
The Potential for Selective Cyclin-Dependent Kinase 4/6 Inhibition in the Therapy for Head and Neck Squamous Cell CarcinomaDouglas Adkins, Jessica Ley, Jared Cohen, et al.Pageof 160